A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
The efficacy and safety of risperidone long acting injectable (LAI) for preventing recurrence of mood episodes in patient with bipolar| disorder was evaluated in a randomized, placebocontrolled study. After a 12 week pen label period with risperidone LAI (n=560), patient who did not experience a rec...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2012
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/9627/1/00000797_93580.pdf |